Amring Pharmaceuticals Inc.
Amring Pharmaceuticals Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a focus on therapeutic areas such as pain management and infectious diseases, Amring is dedicated to providing innovative solutions that meet the evolving needs of healthcare providers and patients. The company’s core products include a range of injectable medications, which are distinguished by their rigorous quality standards and commitment to safety. Amring's strategic operational regions extend across North America, allowing it to effectively serve a diverse market. Notable achievements include securing FDA approvals for several key products, reinforcing its position as a trusted partner in the healthcare sector.
DitchCarbon Score
How does Amring Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amring Pharmaceuticals Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Amring Pharmaceuticals Inc.'s reported carbon emissions
Amring Pharmaceuticals Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. It is important to note that Amring Pharmaceuticals Inc. is a current subsidiary, and any potential emissions data or climate initiatives may be cascaded from its parent organisation. However, no specific initiatives or targets have been identified from the parent company or other sources. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate action. While Amring Pharmaceuticals Inc. has not yet made public commitments or reported emissions, the industry as a whole is moving towards greater transparency and accountability in carbon management.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Amring Pharmaceuticals Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
